Our agency partner, That's Nice, LLC recently completed a case study on the evolving Icagen brand.
Gene family members of the ion channel and solute transporter (SLC) families represent both historical targets of pharmaceutical significance and serve as exciting opportunities for current and future therapeutic development. The common property of ion movement for many of the SLCs lends itself to considering platforms used in ion channel research to enable early drug discovery. In addition, the convergence of advances in both genetic analysis and assay technology bodes well for the identification of the next generation of ion channel and transporter-based drugs in the near future.
Icagen relocates its headquarter office back to North Carolina. Located in the Durham/ RTP area off of Emperor Boulevard.
Triangle Business Journal
Genetic Engineering News